Thus, the present study inspired us to question whether TCF7L1 could play a role in chemotherapy resistance, and whether TCF7L1 could be used as a target to reverse chemotherapy resistance to improve overall gastric cancer survival. This evidence concerns the gene TCF7L1 and gastric cancer.